| CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. | colorectal, |
| Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. | pancreatic,colorectal, |
| As a putative new oncogene that is overexpressed in gastrointestinal malignancies early in the carcinogenesis process, CD24 my be a potential target for early intervention in the prevention and treatment of cancer. | None |
| The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy. | None |
| The CD24 protein inducible expression system is an ideal tool to explore the potential of CD24 as an oncogene and a target for immunotherapy in vitro and in vivo. | None |